New asthma drug shows promise in cutting severe Flare-Ups
NCT ID NCT05329194
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 25 times
Summary
This study looked at how well and how safely the drug tezepelumab works for people aged 12 and older with severe asthma, including groups often left out of research. Over 52 weeks, researchers tracked asthma attacks, hospital visits, and medication use. The goal was to see if tezepelumab could reduce the number of severe flare-ups compared to the year before starting the drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Mobile, Alabama, 36608, United States
-
Research Site
Gilbert, Arizona, 85234, United States
-
Research Site
Long Beach, California, 90815, United States
-
Research Site
Los Angeles, California, 90017, United States
-
Research Site
Rancho Mirage, California, 92270, United States
-
Research Site
Westminster, California, 92683, United States
-
Research Site
Colorado Springs, Colorado, 80907, United States
-
Research Site
New Haven, Connecticut, 06510, United States
-
Research Site
Washington D.C., District of Columbia, 20037, United States
-
Research Site
Chicago, Illinois, 60611, United States
-
Research Site
Lexington, Kentucky, 40509, United States
-
Research Site
New Orleans, Louisiana, 70112, United States
-
Research Site
Upper Marlboro, Maryland, 20772, United States
-
Research Site
Ann Arbor, Michigan, 48109, United States
-
Research Site
Ypsilanti, Michigan, 48197, United States
-
Research Site
Saint Paul, Minnesota, 55109, United States
-
Research Site
St Louis, Missouri, 63110, United States
-
Research Site
Lincoln, Nebraska, 68505, United States
-
Research Site
Omaha, Nebraska, 68114, United States
-
Research Site
Hollis, New York, 11423, United States
-
Research Site
Horseheads, New York, 14845, United States
-
Research Site
Rochester, New York, 14642, United States
-
Research Site
Valhalla, New York, 10595, United States
-
Research Site
Chapel Hill, North Carolina, 27514, United States
-
Research Site
Wilmington, North Carolina, 28401, United States
-
Research Site
Toledo, Ohio, 43617, United States
-
Research Site
Oklahoma City, Oklahoma, 73120, United States
-
Research Site
Altoona, Pennsylvania, 16602, United States
-
Research Site
Philadelphia, Pennsylvania, 19140, United States
-
Research Site
Warwick, Rhode Island, 02886, United States
-
Research Site
Greenville, South Carolina, 29607, United States
-
Research Site
Hendersonville, Tennessee, 37075, United States
-
Research Site
Fort Worth, Texas, 76104, United States
-
Research Site
McKinney, Texas, 75069, United States
-
Research Site
San Antonio, Texas, 78229, United States
-
Research Site
Charlottesville, Virginia, 22903, United States
-
Research Site
Vancouver, Washington, 98664, United States
Conditions
Explore the condition pages connected to this study.